Clinical trial
Evaluation of Ophthalmic Oxymetazoline as an Adjunct Treatment for Acquired Blepharoptosis Due to Periocular Synkinesis.
NCT05945615 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Ophthalmic Oxymetazoline as an Adjunct Treatment for Acquired Blepharoptosis Due to Periocular Synkinesis.
- Lead sponsor
- Milton S. Hershey Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 11, 2024
- Completion date
- January 8, 2026
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.